A Week Where Big Cap Tech Took Over from the Growth Tantrum – Above the 40 (April 9, 2021)

Stock Market Commentary A week ago, the fading of the growth tantrum further solidified my bullish read on the stock market. Last week, big cap tech took over from the growth tantrum. Buyers passed the baton in impression fashion but left small caps behind. Regardless, market dips are attracting buyers in a rotating fashion. The … Read more

A New Investing Opportunity in Genetic Testing Company Invitae

I have been a fan of genetic testing company Invitae (NVTA) for six years. My interest started after I heard co-founder (and now President, CEO, and Chairman) Sean George give a talk at the Stanford Technology Ventures Program. He titled the 2015 talk “Experience Is Your Reward.” George talked about facing down challenges and adversity … Read more

Soliton Reveals More Details About Its Coming Product Launch

Soliton (SOLY) is a pre-launch medical device company specializing in technology for tattoo removal and cellulite reduction. The company is working on extending its RAP (Rapid Acoustic Pulse) technology to other indications. Soliton is still pre-launch, so the company had little to report for its financials in its latest earnings report. Management spent most of … Read more

High-Tech Stocks Break Down In Fallout from Fierce Bear-Bull Battle – Above the 40 (March 5, 2021)

Stock Market Commentary The stock market continued its streak of trickiness. Buyers and sellers played a fierce bear-bull battle starting with one of the biggest fake-out one-day rallies since last September 2nd’s near parabolic run-up. Fresh money flowed into funds to start the month of March to for gains of 2.4% on the S&P 500 … Read more

A Split Personality Market Emerges from the End of Overbought Conditions – Above the 40 (February 19, 2021)

Stock Market Commentary The week ended with a split personality. While the S&P 500 meandered and the NASDAQ flattened, small caps rebounded convincingly. Financials also forged ahead. As a result, the recent end to overbought conditions may only signal (mild) bearish conditions for a portion of the stock market. The Stock Market Indices The S&P … Read more

A New Low in Volatility Brought Fresh Promise to Overbought Stock Market – Above the 40 (February 12, 2021)

Stock Market Commentary After sweeping away bearish signals, the stock market moved right into overbought territory last week. The week started with a small gap up to all-time highs, and the stock market never looked back. More importantly, the volatility index (VIX) hit a new low since the stock market broke down almost a year … Read more

Stock Market Almost Overbought After Sweeping Away Bearish Signals – Above the 40 (February 5, 2020)

In a major display of buying power, AT40 (T2108) surged from 41% to 69% in just a week's time.

Stock Market Commentary Sellers beat a hasty retreat from the stock market as another bearish signal enjoyed a fleeting existence. The last bearish period lasted about three days. The previous bearish period barely survived a day. The stock market’s ability to quickly wipe away bearish signals is impressive. The buying force over the last week … Read more

Why Soliton Sold Off on Good News from the FDA

As highly anticipated, medical device maker Soliton (SOLY) announced the company received approval from the FDA for the cellulite indication of its Rapid Acoustic Pulse (“RAP”) technology. SOLY initially opened on February 1st with a 17.3% gain, but the stock ended the day with a 3.6% gain. Why did Soliton sell off after this good … Read more

Sellers Followed Through On Resolution of Bearish Divergence – Above the 40 (January 29, 2021)

Stock Market Commentary After the recent bearish divergence resolved to the downside, the stock market rebounded sharply. Volatility was over-extended and my favorite breadth indicator plunged at an extreme rate. In that context, the stock market’s subsequent bounce made sense as relief from extreme conditions. The sellers followed through on the resolution of bearish divergence … Read more